MedPath

An observation study of perioperative nintedanib therapy in patients with non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)

Not Applicable
Conditions
non-small-cell lung cancer combined with idiopathic pulmonary fibrosis (IPF)
Registration Number
JPRN-UMIN000039537
Lead Sponsor
Kanazawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
1
Inclusion Criteria

Not provided

Exclusion Criteria

Past history of chest surgery Alternative prior treatment for IPF Past history of chemotherapy or radiation for chest Administration of oxygen therapy Infectious disease requiring treatment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath